Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Cassiopea amends IPO

    Cassiopea S.p.A., Lainate, Italy Business: Dermatology, Infectious Date announced: 2015-06-22 Type: IPO To be raised: Up to CHF192 million ($208.6 million) Shares: 4.8 million Price: CHF30-CHF40 Underwriters: Jefferies;…

    Published on 6/29/2015
  • Natera amends IPO

    Natera Inc., San Carlos, Calif. Business: Diagnostic Date announced: 2015-06-22 Type: IPO To be raised: Up to $106.3 million Shares: 6.3 million Price: $15-$17 Underwriters: Morgan Stanley; Cowen; Piper Jaffray; Baird; …

    Published on 6/29/2015
  • NephroGenex amends follow-on

    NephroGenex Inc. (NASDAQ:NRX), Research Triangle Park, N.C. Business: Renal Date announced: 2015-06-25 Type: Follow-on To be raised: $15 million Shares: 2 million Price prior: $8.75 Underwriter: Aegis Capital …

    Published on 6/29/2015
  • Abivax completes IPO

    Abivax S.A.S. (Euronext:ABVX), Paris, France Business: Infectious, Cancer Date completed: 2015-06-23 Type: IPO Raised: EUR57.7 million ($65.3 million) Shares: 2.7 million Price: EUR21.30 Shares after offering: 9.6 …

    Published on 6/29/2015
  • ADMA completes debt financing

    ADMA Biologics Inc. (NASDAQ:ADMA), Ramsey, N.J. Business: Hematology, Infectious Date completed: 2015-06-22 Type: Debt financing Raised: $16 million Investor: Oxford Finance Note: ADMA drew down $16 million in the first…

    Published on 6/29/2015
  • Advanced Accelerator Applications completes venture financing

    Advanced Accelerator Applications S.A., Saint Genis Pouilly, France Business: Diagnostic, Cancer Date completed: 2015-06-23 Type: Venture financing Raised: EUR23 million ($26 million) Investors: Adage Capital Management…

    Published on 6/29/2015
  • Alder completes follow-on

    Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Bothell, Wash. Business: Antibodies, Autoimmune, Cancer Date completed: 2015-06-25 Type: Follow-on Raised: $200 million Shares: 4.5 million Price: $44.50 Shares after …

    Published on 6/29/2015
  • Ankasa completes venture financing

    Ankasa Regenerative Therapeutics Inc., La Jolla, Calif. Business: Gene/Cell therapy, Musculoskeletal Date completed: 2015-06-23 Type: Venture financing Raised: $8.5 million Investors: Avalon Ventures; Heraeus; …

    Published on 6/29/2015
  • BioPharmX completes follow-on

    BioPharmX Corp. (NYSE-M:BPMX), Menlo Park, Calif. Business: Drug delivery, Genitourinary, Dermatology Date completed: 2015-06-25 Type: Follow-on Raised: $10 million Shares: 3.6 million Price: $2.75 Shares after offering…

    Published on 6/29/2015
  • bluebird bio completes follow-on

    bluebird bio Inc. (NASDAQ:BLUE), Cambridge, Mass. Business: Gene/Cell therapy, Hematology, Neurology Date completed: 2015-06-23 Type: Follow-on Raised: $500 million Shares: 2.9 million Price: $170 Shares after offering:…

    Published on 6/29/2015
  • Catabasis Pharmaceuticals completes IPO

    Catabasis Pharmaceuticals Inc. (NASDAQ:CATB), Cambridge, Mass. Business: Endocrine/Metabolic, Inflammation, Autoimmune Date completed: 2015-06-25 Type: IPO Raised: $60 million Shares: 5 million Price: $12 Shares after …

    Published on 6/29/2015
  • Clementia completes venture financing

    Clementia Pharmaceuticals Inc., Montreal, Quebec Business: Musculoskeletal Date completed: 2015-06-23 Type: Venture financing Raised: $60 million Investors: New Enterprise Associates; UCB Group; RA Capital Management; …

    Published on 6/29/2015
  • Cleveland BioLabs completes private placement

    Cleveland BioLabs Inc. (NASDAQ:CBLI), Buffalo, N.Y. Business: Cancer, Other, Hematology Date completed: 2015-06-25 Type: Private placement Raised: $25 million Shares: 6.5 million Price: $3.87 Shares after offering: 10.5…

    Published on 6/29/2015
  • Confo Therapeutics completes venture financing

    Confo Therapeutics N.V., Brussels, Belgium Business: High throughput screening, Antibodies Date completed: 2015-06-24 Type: Venture financing Raised: EUR3 million ($3.4 million) Investors: Capricorn Venture Partners; …

    Published on 6/29/2015
  • Conkwest completes venture financing

    Conkwest Inc., Cardiff-by-the-Sea, Calif. Business: Cancer Date completed: 2015-06-18 Type: Venture financing Raised: $71 million Investor: Sophisticated investors

    Published on 6/29/2015
  • Dipexium Pharmaceuticals completes follow-on

    Dipexium Pharmaceuticals Inc. (NASDAQ:DPRX), New York, N.Y. Business: Infectious Date completed: 2015-06-25 Type: Follow-on Raised: $18.5 million Shares: 1.5 million Price: $12.50 Shares after offering: 10 million …

    Published on 6/29/2015
  • Endo completes private placement of senior notes

    Endo International plc (NASDAQ:ENDP; TSX:ENL), Dublin, Ireland Business: Neurology, Genitourinary Date completed: 2015-06-24 Type: Private placement of senior notes Raised: $1.6 billion Investor: Institutional investors…

    Published on 6/29/2015
  • Galapagos completes warrant exercise

    Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG), Mechelen, Belgium Business: Autoimmune, Musculoskeletal, Functional genomics Date completed: 2015-06-19 Type: Warrant exercise Raised: EUR4.4 million ($5 million) Shares: 491…

    Published on 6/29/2015
  • Highland Therapeutics completes venture financing

    Highland Therapeutics Inc., Toronto, Ontario Business: Drug delivery Date completed: 2015-06-24 Type: Venture financing Raised: $25 million Investor: Eastern Capital

    Published on 6/29/2015
  • Highland Therapeutics completes venture financing

    Highland Therapeutics Inc., Toronto, Ontario Business: Drug delivery Date completed: 2015-06-24 Type: Venture financing Raised: $25 million Investor: Citibank Note: The financing is a credit facility.

    Published on 6/29/2015
  • Lantheus Holdings completes IPO

    Lantheus Holdings Inc. (NASDAQ:LNTH), North Billerica, Mass. Business: Diagnostic Date completed: 2015-06-24 Type: IPO Raised: $65 million Shares: 10.8 million Price: $6 Shares after offering: 29.4 million Underwriters:…

    Published on 6/29/2015
  • Pluristem Therapeutics completes direct public offering

    Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI), Haifa, Israel Business: Gene/Cell therapy Date completed: 2015-06-25 Type: Direct public offering Raised: $17 million Units: 6.8 million Price: $2.50 (unit) …

    Published on 6/29/2015
  • Portage Biotech completes private placement

    Portage Biotech Inc. (OTCBB:PTGEF; CNSX:PBT.U), Tortola, Virgin Islands Business: Drug delivery, Ophthalmic Date completed: 2015-06-25 Type: Private placement Raised: $5.2 million Shares: 36.8 million Price: $0.14 …

    Published on 6/29/2015
  • Proteome Sciences completes placing

    Proteome Sciences plc (LSE:PRM), Cobham, U.K. Business: Proteomics Date completed: 2015-06-23 Type: Placing Raised: L2.5 million ($4 million) Shares: 13.9 million Price: 18p Shares after offering: 229.4 million …

    Published on 6/29/2015
  • Ritter completes IPO

    Ritter Pharmaceuticals Inc. (NASDAQ:RTTR), Los Angeles, Calif. Business: Gastrointestinal Date completed: 2015-06-24 Type: IPO Raised: $20 million Shares: 4 million Price: $5 Shares after offering: 7.8 million …

    Published on 6/29/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993